Monitoring chronic myeloid leukemia patients responding to treatment with tyrosine kinase inhibitors by real-time quantitative polymerase chain reaction

M Radić Antolic, R Zadro, D Sertić, B Labar - Biochemia medica, 2009 - hrcak.srce.hr
Sažetak Introduction: Historically, many revolutionary advances in therapy for chronic
myeloid leukemia (CML) have been achieved over time, among them most important being …
相关文章

Monitoring CMLl patients responding to treatment with tyrosine kinase inhibitors with real-time quantitative polymerase chain reaction

M Radić Antolic, R Zadro, D Sertić, B Labar - Biochemia medica, 2009 - croris.hr
Sažetak Historically, chronic myeloid leukemia (CML) had many revolutional advances in
therapy implementation. Discovery of new improved drugs like imatinib mesylate (IM) …

Monitoring CMLl patients responding to treatment with tyrosine kinase inhibitors with real-time quantitative polymerase chain reaction

M Radić Antolic, R Zadro, D Sertić, B Labar - Biochemia medica, 2009 - croris.hr
Sažetak Historically, chronic myeloid leukemia (CML) had many revolutional advances in
therapy implementation. Discovery of new improved drugs like imatinib mesylate (IM) …